OSN’s top news of the week

Here are the top stories for Healio.com/Ophthalmology in the past week:
 
Eyenovia ’ s piezo-print latanoprost microdose shows positive results
The EYN PG21 study evaluated 60 eyes of 30 healthy volunteers who received one microdose of piezo-print latanoprost each day for 2 consecutive days. Read more.
 
FDA approves Sun Pharma’s dry eye treatment
Cequa (cyclosporine ophthalmic solution 0.09%), the highest FDA-approved concentration of cyclosporine A and the first to incorporate nanomicellar technology, is indicated to increase tear production. Read more.
 
FDA approves

Read articles from OSN’s Aug. 10 issue online

The cover story in the Aug. 10 issue of Ocular Surface News focused on dry eye therapeutic and diagnostic devices. Here are five more articles from the issue you might want to read:
 
Challenges in Ophthalmology with April Steinert
Contemplating retirement and the years surrounding it
Richard L. Lindstrom, MD, explains his challenge of passing the baton while remaining active in ophthalmology. Read more.
 
Complications Consult
Flap motility sign helps determine extent of anterior capsular tear
Surgeons can decide which steps to take based on the sign, reducing complications and resulting

Iridex posts $3.3 million net loss in second quarter

Iridex reported a net loss of $3.3 million, or $0.28 per share, in the second quarter of 2018 compared with a net loss of $2.75 million, or $0.24 per share, in the second quarter of 2017.
Revenues for the quarter increased to $10.3 million from $10 million in the previous year’s second quarter, according to a press release.
The company’s operating expenses were $7.6 million compared with 2017’s second quarter costs of $7.2 million.
Iridex had cash and cash equivalents of $16 million as of June 30.

VIDEO: Physician leadership development ‘now more than ever’ imperative

AUSTIN, Texas — In this exclusive video perspective from GI Outlook 2018, Karen L. Woods, MD, of Houston Methodist Gastroenterology Associates, discusses her presentation on how to develop leadership in a medical practice.
“This is a very important topic,” Woods told Healio Gastroenterology and Liver Disease. “I think many people don’t have a good understanding of [leadership]. There’s a lot of science behind leadership and developing leadership traits. One very important aspect is the root of your own personality.”
Everyone has several personality